JAPAN AS REPRESENTED BY THE DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in Australia, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are OXXON THERAPEUTICS LTD, VYCELLIX INC and LIGOCYTE PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Republic of Korea | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Inoue Makoto | 7 |
#2 | Shu Tsugumine | 7 |
#3 | Matano Tetsuro | 7 |
#4 | Hara Hiroto | 4 |
#5 | Hironaka Takashi | 3 |
#6 | Ishii Hiroshi | 3 |
#7 | Mori Toyotaka | 3 |
#8 | Hasegawa Hideki | 2 |
#9 | Kondo Kazunari | 1 |
#10 | Sano Shiori | 1 |
Publication | Filing date | Title |
---|---|---|
KR20200047384A | A primer set for detection of severe fever with thrombocytopenia syndrome (sfts) virus | |
US2020353070A1 | Selective cd8-positive t cell-inducing vaccine antigen | |
EP3542818A1 | Infectious disease vaccine using non-infectious paramyxovirus particle | |
AU2010232180A1 | Method for prophylaxis of influenza using vaccine for intranasal administration | |
AU2008325537A1 | West nile virus vaccine, and method for production thereof |